Max Minute: University Of Oxford COVID-19 Vaccine Shows Promising Signs With Creation Of Antibodies

NEW YORK (CBSNewYork) — As we’ve said on many occasions, medical knowledge about the novel coronavirus and the COVID-19 disease it causes is a rapidly evolving science with new and sometimes contradictory studies coming out almost daily. There’s encouraging news about a British vaccine and a new study from Mt. Sinai that supports the vaccine report. In his latest Max Minute report, CBS2’s Dr. Max Gomez discusses the news surrounding the vaccine and the previous studies that dispute the new findings. CORONAVIRUS PANDEMIC Resources, Hotlines, Unemployment & Covering Bills Remote Learning Tools For Parents Teaching At Home Ask Dr. Max Your Health Questions How Make Your Own DIY Face Mask How To Safely Remove Disposable Gloves Tips For Parents To Help Kids Cope Chopper 2 Over Empty NYC Streets, Landmarks Complete Coronavirus Coverage Researchers are having promising results with an experimental vaccine being developed by the University of Oxford and the pharmaceutical company Astrazeneca. The study in the Lancet looked at more than 1,000 healthy adults and found the vaccine induced strong antibody and other immune responses. “What this vaccine does particularly well is trigger both arms of the immune system. So in addition to neutralizing antibodies, which other vaccines… Read full this story

• AstraZeneca COVID-19 vaccine shows promise in elderly, trial results by Christmas
• UK defends Oxford COVID-19 vaccine roll-out among all ages
• EU regulator gets request to approve Oxford COVID-19 vaccine
• Oxford COVID-19 vaccine produces immune response among elderly and young, AstraZeneca says
• Britain approves AstraZeneca-Oxford COVID-19 vaccine
• Oxford University launches Covid-19 vaccine study on children
• AstraZeneca and Oxford's COVID-19 vaccine shows 'an average efficacy of 70%' in trials
• Bharat Biotech says Covid-19 vaccine shows 81% interim efficacy
• Ghana Receives 1st COVID-19 Vaccine Shipment Through Global Sharing Program
• Coronavirus Update: Potential Johnson & Johnson COVID-19 Vaccine Has Advantages Over Moderna, Pfizer
• WHO, UNICEF Say 130 Countries Yet to Administer Any COVID-19 Vaccine
• Oxford COVID-19 trial will look at interim Phase III data after 53 infections: Investigator

Max Minute: University Of Oxford COVID-19 Vaccine Shows Promising Signs With Creation Of Antibodies have 313 words, post on newyork.cbslocal.com at July 20, 2020. This is cached page on CHUTEU. If you want remove this page, please contact us.